Proviron Cenzo Pharma

Description

Pharmacological

Proviron eliminates the effects of impaired androgen production, occurs with age. Therefore, Proviron is suitable for the treatment of conditions caused by insufficient endogenous androgen production. Mesterolone does not impair spermatogenesis. Mesterolone is very well tolerated by the liver. Proviron stimulates the growth, development and function of target organs that are dependent on androgen action. It promotes the development of secondary sexual characteristics in adolescent androgen deficiency states. Proviron also eliminates deficiency symptoms in cases where the functioning of the sex glands ceases after puberty.

The use of the drug Proviron can significantly improve or normalise sperm count and quality, as well as the concentration of fructose in the ejaculate, thereby increasing the possibility of conception.

Pharmacokinetics

After administration, mesterolone is rapidly and almost completely absorbed over a dose range that is 25-100 mg. The maximum serum concentration is.
3.1 ± 1.1 ng / ml – is reached 1.6 ± 0.6 hours after administration of Proviron. Despite this, the level of the active substance in serum decreases with a final half-life of 12-13 hours. 98% of mesterolone binds to plasma proteins 40% to albumin and 58% to sex hormone binding globulin (hSBG).